Preparative isolation of bufalin and cinobufagin from Chinese traditional medicine ChanSu

Journal of Chromatographic Science

Volumn 46, Issue 1, 2008, Pages 81-85

  Yang, Zhen ^a   Luo, Huafei ^a   Wang, Hao ^a   Hou, Huimin ^a  

^a Shanghai Institute of Pharmaceutical Industry   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 38149063511     PISSN: 00219665     EISSN: None     Source Type: Journal    
DOI: 10.1093/chromsci/46.1.81     Document Type: Article

References (18)

1. Z. Hong, K. Chan, and H.W. Yeung. Simultaneous determination of bufadienolides in the traditional Chinese medicine preparation, liu-shen-wan, by liquid chromatography. J. Pharm. Pharmacol. 44: 1023-1026 (1992).
2. E. Akiko, R. Mun-Chual, K. Kanki, and H. Masahiko. Inhibitory effects of bufadienolides on interleukin-6 in MH-60 cells. Notes. J. Nat. Prod. 67: 2070-2072 (2004).
3. K.K. Chen and A. Kovarikove. Pharmacology and toxicology of toad venom. J. Pharm. Sci. 67: 376-380 (1967).
4. A.B. David, D. Pradip, W. Alice, and D. Amitava. Falsely elevated serum digitoxin concentrations due to cross-reactivity of water-extractable digitoxin-like immunoreactivity of Chinese medicine ChanSu: elimination of interference by use of a chemiluminescent assay. Clin. Chim. Acta 300: 151-158 (2000).
5. Y. Masuda, N. Kawazoe, S. Nakajo, T. Yoshida, Y. Kuroiwa, and K. Nakaya. Bufalin induces apoptosis and influences the expression of apoptosis-related genes in human leukemia cells. Leukemia Res. 19: 549-556 (1995).
6. S. Hashimoto, Y. Jing, N. Kawazoe, Y. Masuda, S. Nakajo, T. Yoshida, Y. Kuroiwa, and K. Nakaya. Bufalin reduces the level of topoisomerase II in human leukemia cells and affects the cytotoxicity of anticancer drugs. Leukemia Res. 21: 875-883 (1997).
7. M.B. Pamnani, S. Chen, and H.J. Bryant. Effect of three sodium-potassium adenosine triphosphate inhibitors. Hypertension 18: 316-324 (1991).
8. W.Y. Chan, T.B. Ng, and H.W. Yeung. Examination for toxicity of a Chinese drug, the total grandular secretion product ChanSu in pregnant mice and embryos. Biol. Neonate. 67: 376-380 (1995).
9. L. Krenn and B. Kopp. Bufadienolides from animal and plant sources. Phytochem. 48: 1-29 (1998).
10. P.S. Steyn and F.R. van Heerden. Bufadienolides of plant and animal origin. Nat. Prod. Rep. 15: 397-413 (1998).
11. T. Nogawa, Y. Kamano, A. Yamashita, and G.R. Pettit. Isolation and structure of five new cancer cell growth inhibitory bufadienolides from the Chinese traditional drug ChanSu. J. Nat. Prod. 64: 1148-1152 (2001).
12. J.Y. Yeh, W.J. Huang, S.F. Kan, and P.S. Wang. Effects of bufalin and cinobufagin on the proliferation of androgen dependent and independent prostate cancer cells. Prostate 54: 112-124 (2003).
13. L.S. Zhang, K. Nakaya, T. Yoshida, and Y. Kuroiwa. Bufalin as a potent inducer of differentiation of human myeloid leukemia cells. Biochem. Biophys. Res. Commun. 178: 686-693 (1991).
14. L.S. Zhang, K. Nakaya, T. Yoshida, and Y. Kuroiwa. Induction by bufalin of differentiation of human leukemia cells HL60, U937, and ML1 toward macrophage/monocyte-like cells and its potent synergistic effect on the differentiation of human leukemia cells in combination with other inducers. Cancer Res. 52: 4634-4641 (1992).
15. C.H. Xiao. Chemistry of Chinese traditional medicine. 1st edition. Shanghai Science and Technical Publication, Shanghai 1998, pp. 523-526.
16. M. Ye and D.A. Guo. Analysis of bufadienolides in the Chinese drug ChanSu by high-performance liquid chromatography with atmospheric pressure chemical ionization tandem mass spectrometry. Rapid Commun. Mass Spectrom. 19: 1881-1892 (2005).
17. K. Yoshiaki, Y. Hiroshi, T. Yoshihiro, and K. Manki. The isolation and structure of new bufadienolides, 3-(hydrogensuberates) of resibufogeninin, cinobufagin and bufalin the structures of the so-called "bufotoxins". Tetrahedron Lett. 54: 5673-5676 (1968).
18. Z. Wang, J. Wen, J. Zhang, M. Ye, and D. Guo. Simultaneous determination of four bufadienolides in human liver by high-performance liquid chromatography. Biomed. Chromatogr. 18: 318-322 (2004).